Agios Pharm Company Leadership

Agios Pharm's latest congressional trading

Agios Pharm Management Team Effectiveness

The company has return on total asset (ROA) of (0.2288) % which means that it has lost $0.2288 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.6026 %, meaning that it created $0.6026 on every $100 dollars invested by stockholders. Agios Pharm's management efficiency ratios could be used to measure how well Agios Pharm manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Agios Pharm's Return On Tangible Assets are very stable compared to the past year. As of the 23rd of July 2025, Return On Assets is likely to grow to 0.43, while Return On Capital Employed is likely to drop (0.28). At this time, Agios Pharm's Total Assets are very stable compared to the past year. As of the 23rd of July 2025, Non Current Assets Total is likely to grow to about 732.5 M, while Other Current Assets are likely to drop about 24 M. As of the 23rd of July 2025, Common Stock Shares Outstanding is likely to drop to about 49.8 M. In addition to that, Net Loss is likely to grow to about (253.2 M)

Agios Pharm Workforce Comparison

The company has Profit Margin (PM) of 17.98 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (12.22) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $12.22.

Agios Pharm Insider Trading History

Agios Pharm Notable Stakeholders

The success or failure of an entity such as Agios Pharm often depends on how effective the management is. Agios Pharm management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Agios management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Agios management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.